Cary J. Claiborne - 25 Mar 2024 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADIL	Stock Option (Right to Buy)	Award	$0	+60,000		$0.000000	60,000	25 Mar 2024	Common Stock	60,000	$1.35	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.